Page last updated: 2024-08-18

oleylamine and Pancreatic Neoplasms

oleylamine has been researched along with Pancreatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Habiro, A; Izawa, T; Kohgo, Y; Mizukami, Y; Obara, T; Osanai, M; Tanno, S; Ura, H; Yanagawa, N1
Mizukami, Y1

Other Studies

2 other study(ies) available for oleylamine and Pancreatic Neoplasms

ArticleYear
Requirement of c-jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells.
    Biochemical and biophysical research communications, 2001, Oct-19, Volume: 288, Issue:1

    Topics: Alkyl and Aryl Transferases; Amines; Antineoplastic Agents; Apoptosis; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Genes, ras; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Mutation; Pancreatic Neoplasms; Tumor Cells, Cultured

2001
[Oleylamine (long-chain fatty amine)-induced cell death through MAP kinase pathways in human pancreatic cancer cells].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2002, Volume: 77, Issue:1

    Topics: Amines; Apoptosis; Enzyme Inhibitors; Farnesol; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Tumor Cells, Cultured

2002